Our Mission
Over the past few decades, conjugation chemistry has advanced dramatically, enabling applications across nearly every area of the life sciences. Scientists can now design and construct powerful new molecules by modifying existing biomolecules. Yet many of these innovations remain confined to the research laboratory.
A major challenge is the gap between those who develop bioconjugates and those who need to manufacture and apply them at scale. This disconnect arises from the limited robustness and standardization of conventional conjugation chemistries, the inherent complexity of biomolecules, and the ongoing challenges associated with bioconjugate characterization and purification. Even when a bioconjugate is successfully prepared, it may underperform in practical applications because of poor water solubility, loss of biological activity, aggregation, or precipitation.
These challenges highlight the need for next-generation crosslinkers and linker technologies that can reliably improve the physicochemical and biological properties of bioconjugates.
CellMosaic's mission is to become a global leader in transformative bioconjugation solutions through our proprietary AqueaTether® (AqT®) Technologies and Advanced Conjugation Processes.
Our goal is to make high-quality, innovative, and advanced bioconjugates broadly accessible through reagents, ready-to-use kits, custom bioconjugation services, contract development and manufacturing (CDMO), and strategic partnerships. By combining proprietary technologies with scalable manufacturing expertise, we help customers accelerate the development of bioconjugate therapeutics, diagnostic reagents, and research tools.